3 ASX growth shares I can't help but love

Appen Ltd (ASX:APX) shares are one of three that I think are amongst the best on offer for growth investors right now…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

I think there are a large number of quality growth shares for investors to consider on the local share market.

But because every investor has a limited number of spots in their portfolio, it is important that those spots are taken up by the best available ideas.

With that in mind, I think these three quality shares could easily fit into the portfolio of any growth investor:

Appen Ltd (ASX: APX)

One of my favourite growth shares on the local market is Appen. It is a global leader in the development of high-quality, human-annotated training data for machine learning and artificial intelligence. As this market is expected to grow at an incredible rate over the next decade, I believe Appen is well-placed to continue its strong profit growth for many years to come. This certainly looks set to be the case in FY 2019. The company recently advised that it expects full year underlying EBITDA to be in the range of $85 million to $90 million including the newly acquired Figure Eight business. This represents an increase of 19.2% and 26.2% on the $71.3 million achieved in FY 2018.

REA Group Limited (ASX: REA)

Another top growth share that I would buy is REA Group. It is the dominant force in the Australian residential property listings market and has continued to perform remarkably well, even in the face of lower listing volumes due to the housing market downturn. For the nine months ended March 31, REA Group posted a 15% increase in EBITDA to $404.7 million. Pleasingly, with the housing market tipped to rebound in 2020, REA Group could soon see its property listings return to growth.

ResMed Inc. (ASX: RMD)

A third and final growth share to consider buying is this leading developer of sleep treatment products. ResMed estimates that there are 1 billion people impacted by sleep apnoea worldwide, but the vast majority of these people are undiagnosed and could be at risk of life-threatening conditions. As more and more of these people become diagnosed, I expect demand for its industry-leading products will increase and drive strong profit growth.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Appen Ltd. The Motley Fool Australia has recommended REA Group Limited and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

a man wearing casual clothes fans a selection of Australian banknotes over his chin with an excited, widemouthed expression on his face.
Growth Shares

3 ASX shares that could double over the next decade (or much sooner)

These shares could be positioned to deliver strong returns in the future. Let's find out why.

Read more »

A golden egg with dividend cash flying out of it
Growth Shares

Forget Easter eggs, these ASX shares could be your best buys this month

These shares could be top buys after the Easter break.

Read more »

Two smiling work colleagues discuss an investment at their office.
Growth Shares

3 amazing ASX growth shares I'd buy and hold for the next decade

These shares could be worth holding tightly to for the long term.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Growth Shares

$5,000 invested in Droneshield shares 4 months ago is already worth…

Investors will be thrilled!

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

1 ASX dividend share and 1 ASX growth stock to buy in April

These ASX shares deliver a one-two punch: income now, growth later.

Read more »

Increasing white bar graph with a rising arrow on an orange background.
Growth Shares

Here's what I consider to be the very best ASX 200 share to buy in April

This business looks heavily undervalued to me.

Read more »

Scared people on a rollercoaster holding on for dear life, indicating a plummeting share price
Growth Shares

3 reasons to buy this red-hot ASX healthcare stock today

Brokers think the biotech share is gearing up for its next big move.

Read more »

Multi-ethnic people looking at a camera in a public place and screaming, shouting, and feeling overjoyed.
Growth Shares

2 ASX stocks that could help turn $10,000 into $1 million

I’d think about adding these ASX shares to your portfolio.

Read more »